Oct 6 (Reuters) – * EISAI AND BIOGEN ANNOUNCE U.S. AVAILABILITY OF LEQEMBI® IQLIK™ (LECANEMAB-IRMB) SUBCUTANEOUS INJECTION MAINTENANCE DOSE FOR TREATMENT OF EARLY ALZHEIMER’S DISEASE Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
July 9 (Reuters) - Streaming firm FuboTV on Thursday named Disney executive Alisa Bowen as…
July 9 (Reuters) - Streaming firm FuboTV on Thursday named Disney executive Alisa Bowen as…
July 9 (Reuters) - Streaming firm FuboTV on Thursday named Disney executive Alisa Bowen as…
Berlin (dpa) – After a tiring day of travelling, most people look forward to collapsing…
WASHINGTON, July 9 (Reuters) - IHeartMedia resolved a Federal Communications Commission probe into allegations…
WASHINGTON, July 9 (Reuters) - IHeartMedia resolved a Federal Communications Commission probe into allegations…